CytoSorb approved in EU to remove rivaroxaban during on-pump cardiothoracic surgery

CytoSorb, which is already approved to remove ticagrelor, for the same indication, rapidly reduces rivaroxaban during a typical graft CABG surgical procedure, so that waiting 2-3 days off the drug to allow the anticoagulant to be eliminated from the body is no longer necessary.


Biospace Inc.